Auriga Reiterates eResearch Buy, $10 PT (ERES)

Auriga reiterated its eResearch Technology ERES Buy rating and $10 price target in a research report published today. In the report, Auriga states, "While the Company's EPS guidance of $0.40-$0.50 was below our expectation of $0.55, we continue to believe that, at current multiples, the stock price reflects an even worse-case scenario. Our new estimates reflect the middle of guidance, and represent 22% EPS growth." Shares of eResearch Technology closed Tuesday at $6.38, up 0.47% from Monday's market close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsAurigaHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!